China should expand its immunization program to cover adolescents and adults, ensuring high-risk groups get better vaccine access via schools and hospitals, Zhu Tao, chief scientist of Cansino and a CPPCC member, suggested at the #TwoSessions. It should also leverage medical insurance and commercial products to improve jab payments and health education, he added.